Innovation

Cost-effective electrocatalysts for the production of chlorine

Harvard University Office of Technology Development
posted on 07/13/2011

MARKETS ADDRESSED:
This technology is specifically applicable for fabricating cost-effective catalytic electrode coatings for the chlor-alkali industry. Such coatings, essential to the production of chlorine, generally contain high precious metal contents. The most widely used electrocatalysts contain a large percent of ruthenium. Ruthenium is an expensive rare metal costing in the range of $12,000/kg. A team of Harvard researchers led by Michael Aziz have developed a new electrocatalyst coating with a significantly lower ruthenium content than previously used with equivalent and better performance.

INNOVATIONS & ADVANTAGES:
This is a complex alloy oxide for use as an electrode coating. Electrodes in the chlor-alkali industry currently used are coated with 30 atomic percent (expensive) ruthenium. The coating offered here uses 1/3 to 1/10 that amount of ruthenium, instead using (inexpensive) cobalt or manganese. In addition to a materials cost saving, catalytic activity has been observed to be up to 20 percent superior to that of conventional ruthenium oxide coatings for chloride oxidation and reduction reactions. The alloy oxide offered here also exhibits excellent stability in acidic electrolytes and halogen environments.


Innovation Details
 

File Number: 3811 

Other Information:

Investigator(s)
Michael J. Aziz

Contact
Alan Gordon, (617) 384-5000


IP Protection


License Online

This innovation currently is not available for online licensing. Please contact David Pruskin at Harvard University Office of Technology Development for more information.

Request more info via email request more info
People

Case Manager:

David Pruskin David Pruskin

Innovations (0)


Download Technology Brief (PDF)


Followed By

Follow this innovation



No one is following this innovation.

Organization
Communities
Profile
Related Tags

Find more innovations


February 11, 2009

8,771 members 16,654 innovations 159 organizations

Browse

David Kolb, CEO and chairman of the board, Emunamedica LLC.

"We found tremendous value and benefit in using the iBridge Network..."  read more...